Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 6,316 shares at $43.68 ($276K) on 2014-11-10, disclosed to the SEC on 2014-11-12.
Scheduled sale ($276k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.75 | 16 | $668 | 0.2% |
| 2 | $43.68 | 600 | $26K | 9.5% |
| 3 | $43.68 | 4,200 | $183K | 66.5% |
| 4 | $43.69 | 400 | $17K | 6.3% |
| 5 | $43.69 | 1,100 | $48K | 17.4% |
| Total | $43.68 avg | 6,316 |
| $276K |
| 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |